Literature DB >> 27793641

Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.

Si-Jia Wu1, Yi-Xin Lin2, Hui Ye2, Xian-Ze Xiong2, Fu-Yu Li2, Nan-Sheng Cheng3.   

Abstract

BACKGROUND: Alkaline phosphatase (ALP), gamma-glutamyl transpeptidase (GGT) and lactate dehydrogenase (LDH) are routinely tested before surgery and are easily obtained. They are also the most widely used tumor markers, which have a certain reference value in the diagnosis of hepatocellular carcinoma (HCC). The prognostic values of ALP, GGT and LDH have not been explored deeply and few studies have investigated the prognosis value of them in surgically treated HCC patients. Our study was performed to verify the prognostic significance of preoperative ALP, GGT and LDH in hepatitis B virus (HBV)-related HCC patients receiving curative hepatectomy.
MATERIALS AND METHODS: 469 pathologically confirmed HCC patients who received curative hepatectomy were retrospectively analyzed. Significant clinicopathological factors were collected and analyzed. Independent prognostic factors were identified by the multivariate analysis. Overall survival (OS) and recurrence-free survival (RFS) curves were analyzed and compared between different groups.
RESULTS: Patients with low level of ALP, GGT and LDH have favorable OS and RFS, even in cirrhosis subgroup. ALP, GGT and LDH were also closely related to some important clinicopathological parameters. GGT and LDH were significant independent prognostic factors of both OS and RFS, while ALP was just a significant independent prognostic factor of OS, rather than RFS.
CONCLUSIONS: Preoperative ALP, GGT and LDH could predict prognosis in HBV-related HCC patients who received curative liver resection.
Copyright © 2016 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alkaline phosphatase; Gamma-glutamyl transpeptidase; Hepatocellular carcinoma; Lactate dehydrogenase; Liver resection; Prognostic factor

Mesh:

Substances:

Year:  2016        PMID: 27793641     DOI: 10.1016/j.ijsu.2016.10.033

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  26 in total

1.  Serum NOX2 as a new biomarker candidate for HBV-related disorders.

Authors:  Yuan Xiong; Yuanyuan Ye; Pu Li; Yahui Xiong; Jinju Mao; Yong Huang; Weixian Chen; Bo Wang
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  A nomogram for predicting the risk of postoperative recurrence of hepatitis B virus-related hepatocellular carcinoma in patients with high preoperative serum glutamyl transpeptidase.

Authors:  Jia-Si Zhang; Zhi-Heng Wang; Xing-Gang Guo; Ji Zhang; Jun-Sheng Ni
Journal:  J Gastrointest Oncol       Date:  2022-02

3.  Clinical and laboratory parameters associated with li-rads as diagnostic of liver nodule in patients with cirrhosis.

Authors:  Clarissa Rocha Cruz; Ana Rita Marinho Ribeiro Carvalho; Augusto César Nascimento Maranhão; Dayse Barbosa Aroucha; Gabriela Azevedo Foinquinos; Sylene Rampche Coutinho Carvalho; Luydson Richardson Silva Vasconcelos; Leila Maria Moreira Beltrão Pereira
Journal:  Transl Gastroenterol Hepatol       Date:  2021-10-25

4.  Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors.

Authors:  Johanna Winter; Max M Lenders; Maximilian Gassenmaier; Andrea Forschner; Ulrike Leiter; Benjamin Weide; Mette-Triin Purde; Lukas Flatz; Antonio Cozzio; Martin Röcken; Claus Garbe; Thomas K Eigentler; Nikolaus B Wagner
Journal:  Cancer Immunol Immunother       Date:  2020-10-28       Impact factor: 6.968

5.  Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinoma.

Authors:  Hikmet Akkiz; Brian I Carr; Harika G Bag; Ümit Karaoğullarından; Kendal Yalçın; Nazim Ekin; Ayşegül Özakyol; Engin Altıntaş; Hatice Y Balaban; Halis Şimşek; Ahmet Uyanıkoğlu; Ayhan Balkan; Sedef Kuran; Oğuz Üsküdar; Yakup Ülger; Burak Güney; Anil Delik
Journal:  Int J Clin Pract       Date:  2020-12-12       Impact factor: 2.503

Review 6.  Lactate shuttle: from substance exchange to regulatory mechanism.

Authors:  Xingchen Wang; He Liu; Yingqian Ni; Peibo Shen; Xiuzhen Han
Journal:  Hum Cell       Date:  2021-10-04       Impact factor: 4.174

7.  Peritumoral Dilation Radiomics of Gadoxetate Disodium-Enhanced MRI Excellently Predicts Early Recurrence of Hepatocellular Carcinoma without Macrovascular Invasion After Hepatectomy.

Authors:  Huanhuan Chong; Yuda Gong; Xianpan Pan; Aie Liu; Lei Chen; Chun Yang; Mengsu Zeng
Journal:  J Hepatocell Carcinoma       Date:  2021-06-09

8.  Cancer chemoprevention by oleaster (Elaeagnus angustifoli L.) fruit extract in a model of hepatocellular carcinoma induced by diethylnitrosamine in rats.

Authors:  Zahra Amereh; Nasrin Hatami; Farshad H Shirazi; Saman Gholami; Seyed Hojjat Hosseini; Maryam Noubarani; Mohammad Kamalinejad; Sina Andalib; Fariborz Keyhanfar; Mohammad Reza Eskandari
Journal:  EXCLI J       Date:  2017-07-18       Impact factor: 4.068

9.  Metabolic and microbial signatures in rat hepatocellular carcinoma treated with caffeic acid and chlorogenic acid.

Authors:  Zhan Zhang; Di Wang; Shanlei Qiao; Xinyue Wu; Shuyuan Cao; Li Wang; Xiaojian Su; Lei Li
Journal:  Sci Rep       Date:  2017-07-03       Impact factor: 4.379

10.  Diagnostic value of gamma-glutamyl transpeptidase to alkaline phosphatase ratio combined with gamma-glutamyl transpeptidase to aspartate aminotransferase ratio and alanine aminotransferase to aspartate aminotransferase ratio in alpha-fetoprotein-negative hepatocellular carcinoma.

Authors:  Jiang Li; Haisu Tao; Erlei Zhang; Zhiyong Huang
Journal:  Cancer Med       Date:  2021-06-18       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.